RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE · SPECIFICATIONS AND PRICES REQUIRE FINAL CONFIRMATION
Research Library

PEPTIDES BIO / RESEARCH USE POLICY

Epithalon and MOTS-C: Preserving Research Distinctions

A research guide for Epithalon and MOTS-C that separates peptide identity, research models, and material documentation.

Published Updated Published byPeptides Bio

Research or raw-material evaluation only. Not for human or veterinary use.

The catalogue links below identify the materials related to this guide. Check the linked record for its current pack format and available documentation.

Epithalon and MOTS-C research background

Epithalon is a synthetic tetrapeptide. MOTS-C is a mitochondrial-derived peptide encoded within mitochondrial 12S rRNA. Although both names appear in cellular and aging-related discussions, they refer to different materials and different lines of research.

A useful reading note keeps the product name, model, and endpoint with the original source. Broad topic labels should not replace the material identity used in a paper.

A catalogue record identifies the supplied research material and its stated pack format. It does not reproduce the test material, conditions, or results reported in a separate publication. Apply this check specifically when reviewing Epithalon and MOTS-C: Preserving Research Distinctions.

Evidence-informed research context

Epithalon and MOTS-C should not be grouped under one aging label. Published work describes Epithalon as a tetrapeptide studied in cell systems, while MOTS-C is a mitochondrial-derived peptide encoded within mitochondrial 12S rRNA. A telomerase-focused cell study and a mitochondrial-metabolism source answer different questions.

What the cited work examined

The Epitalon source used normal and cancer cell lines with telomere-related molecular readouts. The MOTS-C source reviews mitochondrial-derived peptide biology and its encoding within mitochondrial DNA. The methods and biological questions are not interchangeable.

How to use this evidence

For Epithalon and MOTS-C, use this literature to frame a defined research question, then retain the exact material wording, model, comparator, endpoint, and limitation from the paper. This protects the distinction between published evidence and the separate material record.

Selected published source: Al-Dulaimi et al., Biogerontology (2025), PMID 40908429; Kim et al., American Journal of Physiology Endocrinology and Metabolism (2020), PMID 32776825.

Research use only. It does not provide medical, veterinary, dosing, administration, safety, or outcome guidance.

Research questions for Epithalon and MOTS-C

Read each source for the named material and model instead of grouping the two under a general cellular-aging label. The material name, experimental system, and endpoint are the minimum fields for a usable comparison.

How to use this guide

Use the sections below to build a source note that connects the product name to a defined research question. Keep the study evidence, the supplied-material record, and any protocol-specific work in separate files. Apply this check specifically when reviewing Epithalon and MOTS-C: Preserving Research Distinctions.

Epithalon and MOTS-C research: compare records without merging identities

An Epithalon and MOTS-C research comparison should start with two separate material identities. The materials may be discussed within broader research themes, but a shared theme does not make their publications, certificates, methods, or batches interchangeable. A sound comparison describes what each source and each document can support, then records any difference openly.

Compare the Epithalon and MOTS-C records by material identity, experimental model, method, endpoint, and document reference. Do not combine results from the two materials when a source does not report the same preparation and system.

Create parallel literature records

For each material, maintain a literature worksheet that includes verified citation, stable DOI or publisher URL, retrieval date, exact material terminology, research question, model or population, comparator, duration, endpoints, preparation details, analytical methods, and stated limitations. Do not compare numerical or descriptive findings until these fields are visible.

  • Keep sources that use different models in separate groups.
  • Record how an endpoint was defined before comparing it with another paper.
  • Preserve the authors’ material wording and do not replace it with a generic category.
  • Mark absent formulation, source, or method details as not documented.
  • Use a primary source for a method-level statement whenever possible.

Epithalon COA and MOTS-C batch documentation

Each material needs its own documentation folder. An Epithalon COA belongs with the exact Epithalon product and lot; a MOTS-C certificate belongs with the exact MOTS-C product and lot. For each file, keep catalogue identifier, labelled amount, lot or batch number, receipt date, receiving condition, internal sample identifier, storage record, available certificate, stated method information, and SDS or MSDS.

Check that the certificate material name, lot, and date correspond to the received item. Note whether an analytical method and acceptance criteria are stated. A document that is incomplete can still be retained, but its limitation must be visible. Do not use a certificate for one material as evidence for the other.

Use a comparison matrix

Comparison field Epithalon record MOTS-C record
Material identity Exact catalogue and source wording Exact catalogue and source wording
Research context Study question, model, comparator, endpoints Study question, model, comparator, endpoints
Batch traceability Lot, COA, storage, receiving documentation Lot, COA, storage, receiving documentation
Unresolved points Missing methods or unclear source details Missing methods or unclear source details

The goal is not to force a conclusion. The goal is to see whether a field is documented, absent, or not comparable. This is more helpful for research planning and avoids false equivalence.

Practical research-documentation workflow

  1. State the comparison question and identify the relevant evidence type.
  2. Open a distinct literature log and batch folder for each material.
  3. Verify primary sources before adding them to the reference list.
  4. Review the exact COA and batch documents against the received lot.
  5. Record internal protocol work separately, with dates, reviewer, and deviations.
  6. Update the matrix when a verified source or new batch document is added.

Evidence boundary

PMID 40908429 reports Epitalon in the stated cell-line experiments and molecular readouts; PMID 32776825 reviews mitochondrial-derived peptides including MOTS-C. The sources use different materials and systems. Neither source reports a shared preparation, a received lot, or a result that can be transferred between the two materials.

Related Epithalon and MOTS-C records

References

  1. PubMed record, PMID 40908429
  2. PubMed record, PMID 32776825
  3. MOTS-c identification study, PMID 25738459

Need a product record?

Build a structured request.

Browse materials